Orion - Company Announcement

Orion Corporation's publication schedules for financial reporting in 2011

ORION CORPORATION   STOCK EXCHANGE RELEASE   10 AUG 2010 AT 11.15  AM EEST

Orion Corporation will publish its financial result for  2010 on Wednesday, 9
February 2011.

The publication dates of the Interim Reports in 2011 are as follows:
Interim Report 1-3/2011      Wednesday, 27 April 2011
Interim Report 1-6/2011       Tuesday, 2 August 2011
Interim Report 1-9/2011      Tuesday, 25 October 2011

Annual Report 2009 will be published during week 10/2011.

The Annual General Meeting is planned to be held on Thursday, 31 March 2011 in
Helsinki.

Orion's financial reports and related presentation material are available on the
Group's home pages at www.orion.fi/investors promptly after the publishing. The
homepage also provides a possibility to register on Orion's mailing lists for
publications and releases.



Orion Corporation

Timo Lappalainen       Jari Karlson
President and CEO      CFO




For additional information, kindly contact:
Susanna Siira, Investor Relations Manager, tel. +358 10 426 2782

Publisher:
Orion Corporation
www.orion.fi/en



Orion is an innovative European R&D-based pharmaceutical and diagnostic company
with a special emphasis on developing medicinal treatments and diagnostic tests
for global markets. Orion develops, manufactures and markets human and
veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic
tests. Orion's pharmaceutical R&D focuses on the following core therapy areas:
central nervous system drugs, cancer and critical care drugs, and Easyhaler(®)
pulmonary drugs.

The Group's net sales in 2009 amounted to EUR 772 million. The Company invested
EUR 95 million in research and development. At the end of 2009, the Group had a
total of 3,100 employees, of whom 2,500 worked in Finland and 600 in other
European countries. Orion's A and B shares are listed on NASDAQ OMX Helsinki.




[HUG#1436808]